355 related articles for article (PubMed ID: 15370936)
1. Methylphenidate and dextroamphetamine abuse in substance-abusing adolescents.
Williams RJ; Goodale LA; Shay-Fiddler MA; Gloster SP; Chang SY
Am J Addict; 2004; 13(4):381-9. PubMed ID: 15370936
[TBL] [Abstract][Full Text] [Related]
2. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
Kollins SH
J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and characteristics of adolescents patients with co-occurring ADHD and substance dependence.
Gordon SM; Tulak F; Troncale J
J Addict Dis; 2004; 23(4):31-40. PubMed ID: 15339712
[TBL] [Abstract][Full Text] [Related]
4. An update on attention deficit disorder.
Harv Ment Health Lett; 2004 May; 20(11):4-7. PubMed ID: 15153391
[No Abstract] [Full Text] [Related]
5. [The medical treatment of attention deficit hyperactivity disorder (ADHD) with amphetamines in children and adolescents].
Frölich J; Banaschewski T; Spanagel R; Döpfner M; Lehmkuhl G
Z Kinder Jugendpsychiatr Psychother; 2012 Sep; 40(5):287-99; quiz 299-300. PubMed ID: 22869222
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine responses to methylphenidate and d-amphetamine: applications to attention-deficit disorder.
Lurie S; O'Quinn A
J Neuropsychiatry Clin Neurosci; 1991; 3(1):41-50. PubMed ID: 7580171
[TBL] [Abstract][Full Text] [Related]
7. The potential for misuse and abuse of medications in ADHD: a review.
Clemow DB; Walker DJ
Postgrad Med; 2014 Sep; 126(5):64-81. PubMed ID: 25295651
[TBL] [Abstract][Full Text] [Related]
8. [Central nervous system stimulants and their potential risk of abuse in hyperkinetic disorders].
Aanonsen NO
Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4040-2. PubMed ID: 10613094
[TBL] [Abstract][Full Text] [Related]
9. ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study.
Dalsgaard S; Mortensen PB; Frydenberg M; Thomsen PH
Addict Behav; 2014 Jan; 39(1):325-8. PubMed ID: 24090624
[TBL] [Abstract][Full Text] [Related]
10. Stimulant medication withdrawal during long-term therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder.
Nolan EE; Gadow KD; Sprafkin J
Pediatrics; 1999 Apr; 103(4 Pt 1):730-7. PubMed ID: 10103294
[TBL] [Abstract][Full Text] [Related]
11. Treatment of attention-deficit-hyperactivity disorder.
Elia J; Ambrosini PJ; Rapoport JL
N Engl J Med; 1999 Mar; 340(10):780-8. PubMed ID: 10072414
[No Abstract] [Full Text] [Related]
12. Prescription Stimulant Use During Pregnancy and Risk of Neurodevelopmental Disorders in Children.
Suarez EA; Bateman BT; Hernandez-Diaz S; Straub L; McDougle CJ; Wisner KL; Gray KJ; Pennell PB; Lester B; Zhu Y; Mogun H; Huybrechts KF
JAMA Psychiatry; 2024 May; 81(5):477-488. PubMed ID: 38265792
[TBL] [Abstract][Full Text] [Related]
13. Illicit use of prescription ADHD medications on a college campus: a multimethodological approach.
DeSantis AD; Webb EM; Noar SM
J Am Coll Health; 2008; 57(3):315-24. PubMed ID: 18980888
[TBL] [Abstract][Full Text] [Related]
14. Attention deficit hyperactivity disorder in children.
Ramchandani P; Joughin C; Zwi M
Clin Evid; 2002 Jun; (7):262-71. PubMed ID: 12230649
[No Abstract] [Full Text] [Related]
15. Attention deficit hyperactivity disorder in children.
Ramchandani P; Joughin C; Zwi M
Clin Evid; 2002 Dec; (8):280-90. PubMed ID: 12603883
[No Abstract] [Full Text] [Related]
16. Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I.
Merkel RL; Kuchibhatla A
Expert Opin Drug Saf; 2009 Nov; 8(6):655-68. PubMed ID: 19785509
[TBL] [Abstract][Full Text] [Related]
17. Managing stimulant medication for attention-deficit/hyperactivity disorder.
Wender EH
Pediatr Rev; 2001 Jun; 22(6):183-90. PubMed ID: 11389305
[No Abstract] [Full Text] [Related]
18. Attention deficit hyperactivity disorder and substance use disorders.
Szobot CM; Bukstein O
Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):309-23, viii. PubMed ID: 18295148
[TBL] [Abstract][Full Text] [Related]
19. [Methylphenidate of retard forms in children and adolescents with ADHD - an overview].
Pelz R; Banaschewski T; Becker K
Klin Padiatr; 2008; 220(2):93-100. PubMed ID: 18157763
[TBL] [Abstract][Full Text] [Related]
20. Central stimulants in the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents. A naturalistic study of the prescription in Sweden, 1977-2007.
Janols LO; Liliemark J; Klintberg K; von Knorring AL
Nord J Psychiatry; 2009 Nov; 63(6):508-16. PubMed ID: 19958258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
